NEW YORK (GenomeWeb News) – Citing the rapid recent growth in the number of multiplex assays making their way to market, a nonprofit medical testing group with industry ties has drawn up a set of recommendations for lab practices and controls.
 
The Clinical and Laboratory Standards Institute’s recommendation, “Verification and Validation of Multiplex Nucleic Acid Assays; Approved Guideline," offers guidelines for analytic verification and validation of multiplex assays and a review of biologic and synthetic reference materials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.